Question 1

What is the catalog number for CXCR4 antagonist 8?

Accepted Answer

The catalog number for CXCR4 antagonist 8 is orb1688674.

Question 2

What sizes are available for CXCR4 antagonist 8?

Accepted Answer

CXCR4 antagonist 8 is available in the following size(s): 25 mg, 50 mg, 100 mg.

Question 3

How many pack sizes does CXCR4 antagonist 8 come in?

Accepted Answer

CXCR4 antagonist 8 is available in 3 different pack sizes.

Question 4

Is CXCR4 antagonist 8 in stock?

Accepted Answer

CXCR4 antagonist 8 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is CXCR4 antagonist 8 used for?

Accepted Answer

CXCR4 antagonist 8

Question 6

Is this product animal-origin-free?

Accepted Answer

Animal-origin-free status, where applicable, is noted on the datasheet under formulation details.

Question 7

Does this product need any special customs documentation to be imported to my country?

Accepted Answer

If you’re outside the EU, UK, or USA, you’re responsible for customs clearance and any related taxes or fees. We provide the standard import documents, such as the Commercial Invoice, Packing List, and Airway Bill, in advance, so let us know early if your customs office needs anything additional for this specific product.

Question 8

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

CXCR4 antagonist 8

Product Specifications

CAS Number

Field of Research

Smiles

Molecular Formula

Molecular Weight

Storage Conditions

Notes

Available Sizes

Frequently Asked Questions

Explore Other Products

Pirh2 (RCHY1) (NM_015436) Human Recombinant Protein

Erio Green B (Technical Grade)

Recombinant Human GNGT1/GNG1 Protein (His Tag)

Freeze Dryer BFFT-308-C

Fibronectin (TV-1), CF488A conjugate, 0.1mg/mL

Elab Fluor® 647 Anti-Mouse CD22 Antibody[Cy34.1]